Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotinic receptor agonist presented as an oromucosal formulation for oromucosal use. It helps adults who are trying to quit smoking by reducing nicotine withdrawal symptoms and cravings.

GNH USA supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niquitin Mini is a nicotine replacement therapy that acts on the nicotinic acetylcholine receptors to aid smoking cessation.

- Smoking cessation: reduces withdrawal symptoms and cravings in adults attempting to quit tobacco use.

Niquitin Mini may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or tingling - Nausea or upset stomach - Hiccups - Throat soreness - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Severe mouth ulceration - Rapid heart rate (tachycardia) - Low blood pressure (hypotension)

Before using Niquitin Mini, consider the following safety measures. - Assess nicotine dependence: confirm the patient is a regular smoker. - Avoid use in non‑smokers or occasional smokers. - Do not combine with other nicotine‑containing products. - Keep out of reach of children and pets. - Monitor cardiovascular status in patients with heart disease. - Store at room temperature: keep in the original pack, protect from moisture.

Nicotine can interact with several medicines; awareness helps prevent complications.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Certain anti‑arrhythmic drugs: nicotine can exacerbate cardiac rhythm disturbances.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine may reduce their blood‑pressure‑lowering effect. - Warfarin: nicotine may alter anticoagulant control. - Insulin or oral hypoglycemics: nicotine can affect blood‑glucose levels.